Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$228.50B | 17.2x | 0.13 | US$131.72 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$216.47B | 92.7x | 3.31 | US$607.16 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$202.40B | 31.9x | 4.59 | US$528.80 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$155.16B | 83.6x | 5.02 | US$105.39 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Stryker | NYSE | Healthcare | Healthcare Equipment & Supplies | US$147.70B | 49.2x | -8.27 | US$386.81 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Danaher | NYSE | Healthcare | Healthcare Equipment & Supplies | US$146.60B | 38.2x | -2.23 | US$203.99 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.4% Upside | Upgrade to Pro+ | |
Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$139.37B | 56.3x | 57.93 | US$152.97 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.1% Downside | Upgrade to Pro+ | |
Medtronic | NYSE | Healthcare | Healthcare Equipment & Supplies | US$110.53B | 26.3x | 4.59 | US$86.22 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Siemens Healthineers ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$65.38B | 31.8x | 1.05 | US$29.37 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | US$65.09B | 38x | 0.91 | US$226.60 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Cencora Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$47.61B | 34.5x | -1.44 | US$245.52 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Edwards Lifesciences | NYSE | Healthcare | Healthcare Equipment & Supplies | US$44.16B | 10.7x | 0.16 | US$74.93 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | US$43.98B | 37.9x | 0.25 | US$88.94 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$42.17B | 21.3x | 0.49 | US$92.02 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Agilent Technologies | NYSE | Healthcare | Healthcare Equipment & Supplies | US$38.96B | 30.8x | 5.2 | US$136.55 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Veeva Systems A | NYSE | Healthcare | Healthcare Equipment & Supplies | US$37.02B | 55.4x | 3.47 | US$229.05 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
IDEXX Labs | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$36.79B | 41.7x | 6.76 | US$449.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
DexCom | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$35.11B | 61.5x | 6.46 | US$89.75 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
ResMed | NYSE | Healthcare | Healthcare Equipment & Supplies | US$34.28B | 27.5x | 0.68 | US$233.17 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Resmed ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$34.22B | 28.3x | 0.68 | US$21.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coloplast A | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$24.98B | 36.6x | -14.13 | US$11.10 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.2% Upside | Upgrade to Pro+ | |
Straumann ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$23.66B | 78.9x | -2.52 | US$14.74 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Koninklijke Philips ADR | NYSE | Healthcare | Healthcare Equipment & Supplies | US$23.34B | -66.9x | -1.18 | US$25.10 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Waters | NYSE | Healthcare | Healthcare Equipment & Supplies | US$22.46B | 35.2x | -28.7 | US$378.62 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
STERIS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$21.68B | 46.5x | -2.07 | US$220.41 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Zimmer Biomet | NYSE | Healthcare | Healthcare Equipment & Supplies | US$20.53B | 23.1x | -2.4 | US$102.93 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$20.07B | 47.4x | 0.2 | US$286.19 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Sonova Holding AG | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$19.63B | 31.5x | -5.42 | US$65.87 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$17.21B | 43.7x | 1.38 | US$86.23 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.7% Upside | Upgrade to Pro+ | |
Illumina | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$16.34B | -12.6x | 0.34 | US$102.48 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Baxter | NYSE | Healthcare | Healthcare Equipment & Supplies | US$15.73B | 145.2x | -1.36 | US$30.78 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Align | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$15.09B | 35.9x | -11.2 | US$202.18 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
West Pharmaceutical Services | NYSE | Healthcare | Healthcare Equipment & Supplies | US$14.83B | 30.5x | -2.09 | US$205.55 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.2% Upside | Upgrade to Pro+ | |
Hologic | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$14.35B | 20.1x | 0.38 | US$63.98 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
Revvity | NYSE | Healthcare | Healthcare Equipment & Supplies | US$13.88B | 51.8x | -0.8 | US$114.09 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.7% Upside | Upgrade to Pro+ | |
Solventum | NYSE | Healthcare | Healthcare Equipment & Supplies | US$12.83B | 16.9x | -0.37 | US$74.29 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Fisher Paykel Healthcare | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.86B | 115.6x | -3.64 | US$19.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avantor | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.85B | 16.6x | 0.14 | US$17.41 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | |
Penumbra Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.73B | 341.9x | -18.7 | US$305.80 | 12.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
CochLear ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.58B | 48.9x | 7.66 | US$87.69 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Globus Medical | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.51B | 125.4x | -2.31 | US$84.54 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Smith&Nephew SNATS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.19B | 36.8x | 0.93 | US$25.58 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.6% Upside | Upgrade to Pro+ | |
Masimo | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$9.75B | 122.9x | -10.89 | US$182.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Henry Schein | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$9.68B | 31.7x | -1.09 | US$77.60 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.2% Upside | Upgrade to Pro+ | |
Glaukos Corp | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8.70B | -53.8x | 6.26 | US$158.68 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.9% Upside | Upgrade to Pro+ | |
Repligen | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$8.37B | -1,030x | 9.4 | US$149.57 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Teleflex | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8.14B | 34.7x | -0.79 | US$175.64 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Bio-Rad Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8B | -4.3x | 0.02 | US$286.42 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.3% Upside | Upgrade to Pro+ | |
Demant ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$7.95B | 24.4x | 0.53 | US$17.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Rad Labs B | NYSE | Healthcare | Healthcare Equipment & Supplies | US$7.88B | -4.4x | 0.02 | US$281.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |